Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2007-07-24
2007-07-24
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S070100, C435S071200, C424S133100, C424S141100, C530S387100, C530S387300, C530S388100
Reexamination Certificate
active
08259321
ABSTRACT:
A Ca2+dependent recombinant antibody that specifically binds to a specific twelve peptide sequence (E D Q V D P R L I D G K) in the activation region of the Protein C has been constructed. The antibody does not bind to Activated Protein C and can be used to inhibit activation of Protein C by thrombin-thrombomodulin, in purification of Protein C, and in treatment of tumors.
REFERENCES:
patent: 4506009 (1985-03-01), Lenhoff et al.
patent: 5147638 (1992-09-01), Esmon et al.
patent: 5202253 (1993-04-01), Esmon et al.
patent: 5298599 (1994-03-01), Rezaie et al.
patent: 5336610 (1994-08-01), Esmon et al.
patent: 5530101 (1996-06-01), Queen
patent: 9007861 (1990-07-01), None
Morrison, Science 229:1201-7, 1985.
D'Angelo et al. J. Clin. Invest. 77:416-425, 1986.
Beckmann Robert J et al “The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA based upon the DNA sequence of cloned human liver cDNAs,”Nucleic Acids Res. 13(14):5233-5246 (1985).
Colman, R.W., et al., Hemostatis and Thrombosis: Basic Principles and Clinical Practice 2nd Ed., p. 263 (J.B.Lippincott, Philadelphia, PA 1987).
Daugherty, et al., Nucl. Acids Res., 19:2471-2476 (1991).
Dreyfus, Marie, et al., “Treatment of Homozygous Protein C Deficiency and Neonatal Purpura Fulminans with a Purified Protein C Concentrate,”New England Journal of Medicine325(22):1565-1568 (1991).
Esmon, Charles T., “The Regulation of Natural Anticoagulant Pathways,”Science235:1348-1352 (1987).
Esmon, Charles T., “the Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation,”J. of Biol. Chem. 264(9):4743-4746 (1989).
Esmon, C. T., et al., at the Joint IABS/CSL Symposium on Standardization in Blood Fractionation including Coagulation Factors, Melbourne, Australia 1986 (reported inDevelop. Biol. Standard., 67:51-57 (S. Karger, Basel, 1987).
Esmon, C.T., et al., at the Joint IABS/CSL Symposium on Standardization in Blood Fractionation incluidng Coagulation Factors, Melbourne, Australia 1986 inDevelop. Biol. Standard, 67:75-82 (S. Karger, Basel, 1987).
Frevssinet J.M., et al., “Inhibition of Human Protein C Activation by Vitamin K-dependent Proteins, Involvement of the y-Carboxyglutamic Acid Domain in Distinct Interactions with the Human Thrombin-Thrombomodulin Complex and Phospholipids,”Thrombosis and Haemostasis58(1):230 (1987).
Goding, James W., “Purification, Fragmentation and Isotopic Labelling,” Monoclonal Antibodies: Principles and Practices 110-113 (Academic Press, Inc.) (1983).
Hendl, Sylvia, et al., “Immunoaffinity purification of protein C with a calcium-dependent monoclonal antibody,” Rev. IberoamerThromb. Hemostasia4(1):25-28 (1991).
Hongo, Tasuku et al.Cell 18:559-566, (1979).
Ikeda, Kyoichi and Johan Stenflo, “A Radioimmunoassay for Protein C.”Thrombosis Research39:297-306 (1985).
Kisiel, inJ. Clin. Invest64, 761-769 (1979).
Kobilka, B.K., et al. “Chimeric α2-β2-Adrenergic Receptors: Delineation of Domains Involved in Effector Coupling and Ligand Binding Specificity”Science240:1310-1316 (1988).
Laurell, Martin, et al., “Characterization of monoclonal antibodies against human protein C specific for the calcium ion-induced comformation or for the activation peptide region,”FEBS Letts. 191(1):75-81 (1985).
Matschiner, et al.,Current Advances in Vitamin K Research, pp. 135-140, John W. Suttie, ed. (Elsevier Science Publishing Co., Inc. 1988).
Max, Edward, et al,J. Biol. Chem.256:5116-5120 (1981).
Nakamura, Satoko and Yoichi Sakata, “Immunoaffinity purification of protein C by using conformation-specific monoclonal antibodies to protein C-calcium ion complex,”Biochimica et Biophysica Act925:85-93 (1987).
Ohlin, Ann-Kristin and Johan Stenflo, “Calcium-dependent Interaction between the Epidermal Growth Factor Precursor-like Region of Human Protein C and a Monoclonal Antibody,”J. Biol. Chem. 262:13798-13804 (1988).
Ohlin, A. K., and J. Stenflo, “High Affinity Calcium to Domaines of Protein C That are Homologus to the Epidermal Growth Factor,”Thrombosis and Haemostatis58(1):230 (1987).
Riechmann.L., M. Clark, H Waldmann. G, Winter, “Reshaping human antibodies for therapy,”Nature, 332:323-327 (1988).
Seligsohn, Uri, et al., “Homozygous Protein C Deficiency Manifested by Massive Venous Thrombosis in the Newborn,”New England J. of Medicine310(9):559-562 (1984).
Stearns, Deborah, et al., “The Interaction of a Ca2+-dependent Monoclonal Antibody with the Protein C Activation Peptide Region,”J. Biol Chem. 263(2):826-832 (1988).
Sugo, et al., Thromb. Hemost. Abstrs., Brussells, 229 (1987).
Summers, M.D. and G.E. Smith, “A manual of methods for baculovirus vectors and insect cell culture procedures”. Texas Agricultural Experimental Station (1987).
Suzuki, Kobi, et al., “Monoclonal Antibodies to Human Protein C: Effects on the Biological Activity of Activated Protein C and the Thrombin-Catalyzed Activation of Protein C,”J. Biochem. 97:127-138 (1985).
Taylor, F. B., et al., “Protein C Prevents the Coagulopathic and Lethal Effects ofEscherichia coliInfusion in the Baboon,”J. Clin. Invest. 79:918-925 (1987).
Verhoeven, M., C. Milstein, G. Winter, “Reshaping Human Antibodies: Grafting an Antilysozyme Activity,”Science, 239:1534-1536 (1988).
Vukovich, Thomas, et al., “Replacement therapy for a homozygous protein C deficiency-state using a concentrate of human protein C and S,”British J. of Haematology70:435-440 (1988).
Wakabayashi, et al.,J. Biol. Chem.261, 11097-11105 (1986).
Esmon Charles T.
Rezaie Alireza
Canella Karen A.
Fulbright & Jaworski
Oklahoma Medical Research Foundation
LandOfFree
Calcium binding recombinant antibody against protein C does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Calcium binding recombinant antibody against protein C, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium binding recombinant antibody against protein C will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3756011